title: Equine Herpesvirus 1 Multiply Inserted Transmembrane Protein pUL43 Cooperates with pUL56 in Downregulation of Cell Surface Major Histocompatibility Complex Class I.
abstract: Herpesviruses have evolved an array of strategies to counteract antigen presentation by major histocompatibility complex class I (MHC-I). Previously, we identified pUL56 of equine herpesvirus 1 (EHV-1) as one major determinant of the downregulation of cell surface MHC-I (G. Ma, S. Feineis, N. Osterrieder, and G. R. Van de Walle, J. Virol. 86:3554-3563, 2012, http://dx.doi.org/10.1128/JVI.06994-11; T. Huang, M. J. Lehmann, A. Said, G. Ma, and N. Osterrieder, J. Virol. 88:12802-12815, 2014, http://dx.doi.org/10.1128/JVI.02079-14). Since pUL56 was able to exert its function only in the context of virus infection, we hypothesized that pUL56 cooperates with another viral protein. Here, we generated and screened a series of EHV-1 single-gene deletion mutants and found that the pUL43 orthologue was required for downregulation of cell surface MHC-I expression at the same time of infection as when pUL56 exerts its function. We demonstrate that the absence of pUL43 was not deleterious to virus growth and that expression of pUL43 was detectable from 2 h postinfection (p.i.) but decreased after 8 h p.i. due to lysosomal degradation. pUL43 localized within Golgi vesicles and required a unique hydrophilic N-terminal domain to function properly. Finally, coexpression of pUL43 and pUL56 in transfected cells reduced the cell surface expression of MHC-I. This process was dependent on PPxY motifs present in pUL56, suggesting that late domains are required for pUL43- and pUL56-dependent sorting of MHC class I for lysosomal degradation.
  
  
  OBJECTIVE
  We describe here that the poorly characterized herpesviral protein pUL43 is involved in downregulation of cell surface MHC-I. pUL43 is an early protein and degraded in lysosomes. pUL43 resides in the Golgi vesicles and needs an intact N terminus to induce MHC-I downregulation in infected cells. Importantly, pUL43 and pUL56 cooperate to reduce MHC-I expression on the surface of transfected cells. Our results suggest a model for MHC-I downregulation in which late domains in pUL56 are required for the rerouting of vesicles containing MHC-I, pUL56, and pUL43 to the lysosomal compartment.
authors.affiliation: Institut für Virologie, Zentrum für Infektionsmedizin-Robert von Ostertag-Haus, Freie Universität Berlin, Berlin, Germany.
authors.forename: Teng
authors.initials: T
authors.lastname: Huang
authors.affiliation: Institut für Virologie, Zentrum für Infektionsmedizin-Robert von Ostertag-Haus, Freie Universität Berlin, Berlin, Germany.
authors.forename: Guanggang
authors.initials: G
authors.lastname: Ma
authors.affiliation: Institut für Virologie, Zentrum für Infektionsmedizin-Robert von Ostertag-Haus, Freie Universität Berlin, Berlin, Germany no.34@fu-berlin.de.
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Osterrieder
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D015536:Down-Regulation; D017353:Gene Deletion; D004861:Herpesvirus 1, Equid / Q000235:genetics / Q000276:immunology* / Q000502:physiology*; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis*; D006736:Horses; D054884:Host-Pathogen Interactions; D057131:Immune Evasion; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D015395:Histocompatibility Antigens Class I; D014764:Viral Proteins
references.citation: J Virol. 2004 Jan;78(1):424-40
references.pmid: 14671123
references.citation: J Virol. 2002 Mar;76(6):2952-63
references.pmid: 11861861
references.citation: J Virol. 2008 Jun;82(11):5220-33
references.pmid: 18353951
references.citation: PLoS Pathog. 2008 May;4(5):e1000080
references.pmid: 18516302
references.citation: Arch Virol. 2009;154(5):833-42
references.pmid: 19387789
references.citation: Nat Rev Immunol. 2009 Jul;9(7):503-13
references.pmid: 19498380
references.citation: Virology. 2009 Dec 20;395(2):172-81
references.pmid: 19819514
references.citation: Channels (Austin). 2011 Jan-Feb;5(1):79-88
references.pmid: 21057195
references.citation: PLoS One. 2011;6(4):e18556
references.pmid: 21602908
references.citation: Immunity. 2011 Aug 26;35(2):161-8
references.pmid: 21867926
references.citation: PLoS One. 2011;6(10):e25742
references.pmid: 22046246
references.citation: Nat Rev Immunol. 2011 Dec;11(12):823-36
references.pmid: 22076556
references.citation: J Virol. 2012 Apr;86(7):3554-63
references.pmid: 22278226
references.citation: Biotechniques. 2012 Jul;53(1):23-4
references.pmid: 22780315
references.citation: PLoS One. 2013;8(8):e72050
references.pmid: 23951282
references.citation: Vet Microbiol. 2013 Nov 29;167(1-2):123-34
references.pmid: 23890672
references.citation: J Virol. 2014 Nov;88(21):12802-15
references.pmid: 25165105
references.citation: Vet Microbiol. 2015 Mar 23;176(1-2):32-9
references.pmid: 25582614
references.citation: J Cell Sci. 2004 May 1;117(Pt 11):2357-67
references.pmid: 15126635
references.citation: Int J Biochem Cell Biol. 2005 Feb;37(2):260-6
references.pmid: 15474971
references.citation: J Gen Virol. 1991 Apr;72 ( Pt 4):897-906
references.pmid: 1849972
references.citation: J Biol Chem. 1992 May 5;267(13):9241-7
references.pmid: 1374389
references.citation: Virology. 1992 Jul;189(1):304-16
references.pmid: 1318606
references.citation: Virology. 1994 Feb 15;199(1):81-8
references.pmid: 8116257
references.citation: Nature. 1995 Jun 1;375(6530):415-8
references.pmid: 7760936
references.citation: Virology. 1996 Mar 15;217(2):442-51
references.pmid: 8610435
references.citation: J Virol. 1996 Jun;70(6):4110-5
references.pmid: 8648751
references.citation: J Virol. 1996 Nov;70(11):7663-8
references.pmid: 8892886
references.citation: J Mol Biol. 1997 Mar 14;266(5):993-1001
references.pmid: 9086276
references.citation: J Gen Virol. 1998 May;79 ( Pt 5):1197-203
references.pmid: 9603335
references.citation: Biochim Biophys Acta. 1998 Aug 14;1404(1-2):77-84
references.pmid: 9714747
references.citation: Virus Res. 1999 Feb;59(2):165-77
references.pmid: 10082388
references.citation: Virology. 2005 Apr 10;334(2):224-33
references.pmid: 15780872
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5144-9
references.pmid: 15793001
references.citation: Biotechniques. 2006 Feb;40(2):191-7
references.pmid: 16526409
references.citation: Can J Physiol Pharmacol. 2006 Jan;84(1):5-14
references.pmid: 16845885
references.citation: J Virol. 2007 Sep;81(17):9034-49
references.pmid: 17567702
references.citation: PLoS Pathog. 2007 Nov;3(11):e160
references.pmid: 17997600